The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysisMaarten M.J. Wijnenga, Martin J. van den Bent, Marion Smits et al.|Neuro-Oncology|2017Cited by 330
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteriaC. Mircea S. Tesileanu, Martin J. van den Bent, Linda Dirven et al.|Neuro-Oncology|2019Cited by 213
The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation studyMartinus P. G. Broen, Martin J. van den Bent, Alida A. Postma et al.|Neuro-Oncology|2018Cited by 205